1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, hereditary spastic paraplegia 50, nervous system disorder, palsy, paraplegiaRecruitingPhase 32026-04-20NCT06692712